In Conversation

It has become evident during the pandemic that Turkey has a well-established and capable healthcare system with experienced healthcare professionals (HCPs). Considering all these aspects, double-digit…

The Turkish authorities have chosen, in many cases, a PPP model where private investors come in and run the hospitals. The entire clinical piece remained with…

Companies should consider going beyond and investing in R&D localization in Turkey; they will be surprised by the potential

Our products create real value for patients, saving lives or radically improving their quality of life, but they need to be available for them

The most important milestone achieved by GEN happened this year, when the company became public, listing its stock on the Istanbul Stock Exchange. Although it is…

Our aim is to produce Turkovac as soon as possible to inoculate the Turkish nation, and later send it to other countries, especially the ones that…

We are not interested in mass production products, rather focusing on niche generics where there are far more opportunities worldwide

Celltrion is a true pioneer in biosimilars. Our objective at the moment is to launch at least one product per year; we try to be very…

Agility is of paramount importance and the COVID-19 pandemic has engendered huge changes in market dynamics

Polifarma is a secure port and a trusted partner because we are transparent and take care of our customers and suppliers

Turkey has become a regional hub in terms of R&D, design, production, logistics and management for investors especially in the life sciences industry because of the…

While scaling our company by uniting with others would make us more competitive on a global scale, we still believe it is possible to be successful…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here